Prospective Observational Cohort Study of Critically Ill Patients With Covid-19 in Sweden

Completed

• Conditions: Covid-19; Critical Illness
• Interventions: Other: Observational study

• Registration Number: NCT04382417
• Lead Sponsor: Region Västmanland

Brief Summary

The study will prospectively collect data from patients with Covid-19 admitted to the Västerås Intensive Care Unit, Västerås Hospital. Demographic, clinical, radiographic and laboratory characteristics will be recorded. Analysis of data to identify predictors of disease severity, mortality and treatment response.

Detailed Description

Not available

Study Timeline

• Study Start: 2020-03-26
• Study First Submitted: 2020-05-04
• Study First Submitted QC: 2020-05-08
• Study First Posted: 2020-05-11
• Primary Completion: 2020-11-12
• Study Completion: 2020-11-12
• Status Verified: 2021-03
• Last Update Submitted: 2021-03-11
• Last Update Posted: 2021-03-15

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 57

Inclusion Criteria

• Patients admitted to the Intensive Care Unit with biological samples positive for SARS-CoV-2.
• Patients admitted to the Intensive Care Unit with one or more negative tests but with clinical and radiological characteristics highly suggestive of SARS-CoV-2 and thus considered positive for the disease.

Exclusion Criteria

• None.

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Arm && Interventions

Group	Intervention	Description
Covid-19	Observational study	Patients with verified or highly suggestive Covid-19 diagnosis and Intensive Care treatment.

Primary Outcome Measures

Name	Time	Method
All-cause mortality	At 90 days follow-up after admittance to Intensive Care

Secondary Outcome Measures

Name	Time	Method
Hospital length of stay	Until 90 days after admittance to Intensive Care
Number of days on mechanical ventilation	Until 90 days after admittance to Intensive Care
Number of patients receiving vasopressor support	Until 90 days after admittance to Intensive Care
Number of patients receiving renal replacement therapy	Until 90 days after admittance to Intensive Care
ICU length of stay	Until 90 days after admittance to Intensive Care
Patient characteristics	At admission to ICU

Trial Locations

Locations (1)

Intensive Care Unit, Västerås Hospital; 🇸🇪 Västerås, Västmanland, Sweden